骨移植片市場レポート：2031年までの動向、予測、競合分析

世界の骨移植片市場は、病院・歯科クリニックと整形外科・外傷センター市場に機会があり、将来性が期待されます。骨移植片の世界市場は、2025年から2031年にかけてCAGR 9.2%で成長すると予想されます。この市場の主な促進要因は、医療従事者の間でアログラフトのアドヒアランスが高まっていること、ヘルスケアへの支出が増加していること、関節再建術や脊椎固定術などの外科手術件数が拡大していることです。

• Lucintel社は、タイプ別では脱灰骨マトリックスが予測期間中最大のセグメントであり続けると予測しています。
• 最終用途カテゴリーでは、病院・歯科クリニックが予測期間中も大きなセグメントであり続けると思われます。
• 地域別では、北米が予測期間中最大の地域であり続けると思われます。

骨移植片市場の戦略的成長機会

骨移植片市場は、ヘルスケアが進化し、高度な外科手術ソリューションへの需要が高まるにつれて、大きく成長する見込みです。整形外科疾患の有病率の上昇と加工技術の革新により、市場プレーヤーには提供製品を強化する多くの機会があります。こうした戦略的成長手段を活用することで、企業は市場での存在感を高めながら、患者の転帰を改善することができます。こうした機会を理解することは、この競合情勢で成功を収めようとする利害関係者にとって不可欠です。

• 新興市場への進出：新興国ではヘルスケアのインフラが整備され、骨移植片の需要が高まっています。
• 革新的な同種移植片製品の開発：生体活性移植片や複合移植片など、次世代の骨移植片を開発するための研究開発に投資することで、外科医の進化するニーズに対応し、手術成績を向上させることができます。
• ヘルスケア・プロバイダーとの連携強化：病院や整形外科診療所との戦略的パートナーシップの構築により、同種移植片の採用を促進し、ヘルスケア提供者がこれらのソリューションを効果的に利用できるよう十分な設備を確保することができます。
• 規制遵守と品質保証の重視：規制の枠組みを強化し、厳格な品質管理を徹底することで、同種移植片製品の信頼性を高め、医療従事者や患者の信頼を得ることができます。
• デジタル技術の統合：遠隔医療やデータ分析などのデジタル・ツールを活用することで、骨移植片に関する患者教育やフォローアップ・ケアが改善され、全体的な満足度と治療成績が向上します。

骨移植片市場には、利害関係者が技術革新を推進し、患者ケアを改善するために活用できる、さまざまな戦略的成長機会があります。新興国市場、製品開発、戦略的提携に注力することで、企業は競争力を高めることができます。情勢が進化し続ける中、このような機会への適応力と対応力を維持することが、長期的な成功には不可欠です。

骨移植片市場促進要因・課題

骨移植片市場は、技術の進歩や整形外科手術の普及率上昇など、様々な要因によって力強い成長を遂げています。骨の修復と再建における効果的なソリューションへの需要が高まるにつれ、利害関係者は技術革新と拡大の機会を積極的に探っています。しかし、市場は規制上のハードルや安全性への懸念など、いくつかの課題にも直面しています。これらの促進要因と課題を理解することは、この進化する状況を効果的にナビゲートすることを目指す利害関係者にとって極めて重要です。

骨移植片市場を牽引している要因は以下の通りです：

• 整形外科疾患の増加：骨折や変性疾患を含む整形外科疾患の有病率の増加は、外科的介入のための効果的な治療ソリューションとして骨移植片の需要を促進しています。
• 加工技術の進歩：組織処理と保存方法の革新により、骨移植片の安全性と有効性が向上し、ヘルスケアプロバイダーや患者にとってより魅力的なものとなっています。
• 移植片の受容の拡大：骨移植片の利点に関する医療従事者の認識と教育の高まりは、外科手術における受け入れと利用の拡大につながり、市場の成長を促進しています。
• ヘルスケアインフラの拡大：特に新興経済諸国では、ヘルスケア施設の開発が進んでおり、骨移植片を含む高度な外科治療へのアクセスが向上しています。
• 研究開発投資の増加：再生医療や組織工学の研究に対する資金提供の増加は、次世代の同種移植片製品の開発を促進し、市場の成長をさらに刺激しています。

骨移植片市場における課題は以下の通りです：

• 規制上のハードル：規制上のハードル：骨移植片の承認に関する厳しい規制要件は、製品上市の遅れを生み、新たなイノベーションの市場参入を妨げ、競争を制限する可能性があります。
• 安全性への懸念：感染症のトランスミッションや同種移植片の長期有効性に関する問題は、医療従事者や患者の安全性への懸念を高め、採用率に影響を与える可能性があります。
• 移植片製品の高コスト：骨移植片の調達と加工に伴う高コストは、特に予算が限られているコストに敏感なヘルスケア市場においては、採用の障壁となり得ます。

骨移植片市場は、技術の進歩やヘルスケアへのアクセスの増加など、複数の促進要因・課題によって支えられているが、規制上の問題や安全性への懸念など、重大な課題も乗り越えなければならないです。こうした課題に対処することは、骨移植片市場の成長ポテンシャルを活かそうとする利害関係者にとって極めて重要です。持続的な成功のためには、イノベーションとコンプライアンスを両立させる戦略的アプローチが不可欠です。

目次

第1章 エグゼクティブサマリー

第2章 世界の骨移植片市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2019年から2031年までの市場動向と予測分析

• マクロ経済動向（2019-2024年）と予測（2025-2031年）
• 世界の骨移植片市場の動向（2019～2024年）と予測（2025～2031年）
• 世界の骨移植片市場：タイプ別
  • 皮質骨同種移植
  • 海綿骨同種移植
  • 皮質海綿骨同種移植
  • 脱灰骨基質
• 世界の骨移植片市場：用途別
  • 歯科
  • 脊椎
  • 再建と外傷学
  • その他
• 世界の骨移植片市場：最終用途別
  • 病院・歯科医院
  • 整形外科・外傷センター
  • その他

第4章 2019年から2031年までの市場動向と予測分析：地域別

• 地域別：世界骨移植片市場
• 北米の骨移植片市場
• 欧州の骨移植片市場
• アジア太平洋地域の骨移植片市場
• その他地域の骨移植片市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の骨移植片市場の成長機会：タイプ別
  • 世界の骨移植片市場の成長機会：用途別
  • 世界の骨移植片市場の成長機会：最終用途別
  • 世界の骨移植片市場の成長機会：地域別
• 世界の骨移植片市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界の骨移植片市場の生産能力拡大
  • 世界の骨移植片市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Zimmer Biomet
• Medtronic
• Lynch Biologics
• Biomatlante
• Stryker
• Royal Biologics
• Johnsons & Johnsons
• Smith & Nephew
• Baxter
• Xtant Medical

The future of the global bone allograft market looks promising with opportunities in the hospital & dental clinic and orthopedic & trauma center markets. The global bone allograft market is expected to grow with a CAGR of 9.2% from 2025 to 2031. The major drivers for this market are the increasing allograft adherence among healthcare providers, growing expenditures for healthcare, and an expanding number of surgical procedures, such as joint reconstruction and spinal fusion surgeries.

• Lucintel forecasts that, within the type category, demineralized bone matrix will remain the largest segment over the forecast period.
• Within the end-use category, hospital & dental clinics will remain a larger segment over the forecast period.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Bone Allograft Market

The bone allograft market is evolving rapidly, driven by technological advancements and shifting healthcare demands. As orthopedic surgeries become more prevalent, the need for safe and effective bone graft solutions is increasing. Innovations in preservation methods, processing technologies, and regulatory frameworks are shaping the landscape. Additionally, growing awareness about the benefits of allografts is leading to a more significant market presence. Understanding these emerging trends is crucial for stakeholders looking to navigate this dynamic environment effectively.

• Increased Demand for Minimally Invasive Techniques: There is a notable shift toward minimally invasive surgical techniques, which often require bone allografts, leading to enhanced patient recovery and reduced hospital stays.
• Technological Innovations in Processing: Advancements in processing technologies, such as freeze-drying and sterilization methods, are improving the safety and efficacy of bone allografts, making them more appealing to surgeons and patients.
• Growth of Regenerative Medicine: The integration of bone allografts into regenerative medicine practices is expanding, as healthcare providers seek to harness the body's natural healing processes to enhance recovery outcomes.
• Expansion of Tissue Banks: The establishment and growth of tissue banks are facilitating the increased availability of bone allografts, ensuring better access to healthcare facilities and enhancing patient treatment options.
• Rising Acceptance of Allografts: Growing awareness and education about the benefits of allografts among healthcare professionals and patients are leading to greater acceptance and utilization in surgical procedures.

The bone allograft market is undergoing transformative changes driven by technological, regulatory, and educational advancements. As these trends continue to develop, they will significantly impact how bone allografts are utilized in clinical practice, ultimately improving patient outcomes and expanding the market further. Stakeholders must stay informed to adapt to this evolving landscape.

Recent Developments in the Bone Allograft Market

The bone allograft market is witnessing transformative developments that reflect the growing demand for innovative solutions in orthopedic and reconstructive surgeries. With advancements in processing technologies, regulatory changes, and increased collaboration among stakeholders, the landscape is evolving rapidly. The focus on enhancing safety, efficacy, and accessibility is reshaping how bone allografts are perceived and utilized in clinical practice. Understanding these recent developments is crucial for industry players and healthcare professionals navigating this dynamic sector.

• Advancements in Preservation Techniques: New preservation methods, including advanced freeze-drying and cryopreservation, are improving the longevity and safety of bone allografts, thereby enhancing their usability in surgical applications.
• Regulatory Framework Improvements: Recent updates to regulatory standards in various countries are streamlining the approval processes for bone allografts, allowing for quicker market entry and increased confidence among healthcare providers.
• Collaboration Between Institutions: Increased partnerships between hospitals, universities, and tissue banks are fostering innovation in bone allograft research and development, leading to enhanced product offerings and improved patient outcomes.
• Focus on Patient Education: There is a growing emphasis on educating patients about the benefits and risks associated with bone allografts, which is contributing to higher acceptance rates and informed decision-making in surgical options.
• Expansion of Market Reach: The global bone allograft market is expanding into emerging economies, driven by rising healthcare infrastructure investments and increasing awareness of advanced surgical techniques, leading to greater accessibility.

The recent developments in the bone allograft market illustrate a concerted effort to enhance the quality and availability of these critical surgical materials. As technologies advance and collaborations increase, the market is poised for further growth. Stakeholders must remain adaptive and informed to leverage these developments for improved patient care and clinical outcomes.

Strategic Growth Opportunities for Bone Allograft Market

The bone allograft market is poised for significant growth as healthcare systems evolve and the demand for advanced surgical solutions increases. With a rising prevalence of orthopedic conditions and innovations in processing technologies, there are numerous opportunities for market players to enhance their offerings. By capitalizing on these strategic growth avenues, companies can improve patient outcomes while expanding their market presence. Understanding these opportunities is essential for stakeholders looking to thrive in this competitive landscape.

• Expansion into Emerging Markets: As healthcare infrastructure improves in emerging economies, there is a growing demand for bone allografts, presenting opportunities for companies to establish a foothold in these underserved regions.
• Development of Innovative Allograft Products: Investing in research and development to create next-generation bone allografts, such as bioactive and composite grafts, can meet the evolving needs of surgeons and improve surgical outcomes.
• Enhanced Collaboration with Healthcare Providers: Building strategic partnerships with hospitals and orthopedic practices can facilitate the adoption of allografts, ensuring that healthcare providers are well-equipped to utilize these solutions effectively.
• Focus on Regulatory Compliance and Quality Assurance: Strengthening regulatory frameworks and ensuring rigorous quality control can enhance the credibility of allograft products, instilling trust among healthcare professionals and patients.
• Integration of Digital Technologies: Utilizing digital tools such as telemedicine and data analytics can improve patient education and follow-up care related to bone allografts, enhancing overall satisfaction and outcomes.

The bone allograft market presents a range of strategic growth opportunities that stakeholders can leverage to drive innovation and improve patient care. By focusing on emerging markets, product development, and strategic collaborations, companies can enhance their competitive edge. As the landscape continues to evolve, staying adaptable and responsive to these opportunities will be critical for long-term success.

Bone Allograft Market Driver and Challenges

The bone allograft market is experiencing robust growth driven by various factors, including technological advancements and an increasing prevalence of orthopedic surgeries. As the demand for effective solutions in bone repair and reconstruction rises, stakeholders are actively exploring opportunities for innovation and expansion. However, the market also faces several challenges, including regulatory hurdles and concerns over safety. Understanding these drivers and challenges is crucial for stakeholders aiming to navigate this evolving landscape effectively.

The factors responsible for driving the bone allograft market include:

• Increasing Incidence of Orthopedic Conditions: The rising prevalence of orthopedic disorders, including fractures and degenerative diseases, is fueling the demand for bone allografts as effective treatment solutions for surgical interventions.
• Technological Advancements in Processing: Innovations in tissue processing and preservation methods are enhancing the safety and efficacy of bone allografts, making them more appealing to healthcare providers and patients alike.
• Growing Acceptance of Allografts: Increasing awareness and education among healthcare professionals about the benefits of bone allografts are leading to greater acceptance and utilization in surgical procedures, thereby driving market growth.
• Expansion of Healthcare Infrastructure: The ongoing development of healthcare facilities, particularly in emerging economies, is improving access to advanced surgical treatments, including those involving bone allografts.
• Rising Investment in Research and Development: Increased funding for research into regenerative medicine and tissue engineering is fostering the development of next-generation allograft products, further stimulating market growth.

Challenges in the bone allograft market are:

• Regulatory Hurdles: Stringent regulatory requirements for the approval of bone allografts can create delays in product launches, hindering market entry for new innovations and limiting competition.
• Safety Concerns: Issues related to the transmission of infectious diseases and the long-term efficacy of allografts raise safety concerns among healthcare providers and patients, potentially affecting adoption rates.
• High Costs of Allograft Products: The high cost associated with procuring and processing bone allografts can be a barrier to adoption, especially in cost-sensitive healthcare markets where budgets are limited.

The bone allograft market is propelled by multiple drivers such as technological advancements and increasing healthcare access, but it must also navigate significant challenges, including regulatory issues and safety concerns. Addressing these challenges will be vital for stakeholders seeking to capitalize on the growth potential of this market. A strategic approach that balances innovation with compliance will be essential for sustained success.

List of Bone Allograft Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies bone allograft companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bone allograft companies profiled in this report include-

• Zimmer Biomet
• Medtronic
• Lynch Biologics
• Biomatlante
• Stryker
• Royal Biologics
• Johnsons & Johnsons
• Smith & Nephew
• Baxter
• Xtant Medical

Bone Allograft by Segment

The study includes a forecast for the global bone allograft market by type, application, end use, and region.

Bone Allograft Market by Type [Analysis by Value from 2019 to 2031]:

• Cortical Bone Allografts
• Cancellous Bone Allografts
• Corticocancellous Bone Allografts
• Demineralized Bone Matrices

Bone Allograft Market by Application [Analysis by Value from 2019 to 2031]:

• Dental
• Spine
• Reconstruction & Traumatology
• Others

Bone Allograft Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals & Dental Clinics
• Orthopedic & Trauma Centers
• Others

Bone Allograft Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Bone Allograft Market

The bone allograft market is experiencing significant growth driven by advancements in surgical techniques, increased demand for orthopedic and dental procedures, and innovations in allograft processing and storage. Bone allografts are increasingly recognized for their ability to promote healing and support various reconstructive surgeries. The landscape is evolving in the United States, China, Germany, India, and Japan, where regulatory frameworks, research initiatives, and market dynamics are influencing the availability and application of bone allografts. These developments are crucial in addressing the rising incidence of bone-related disorders and enhancing surgical outcomes.

• United States: In the United States, the bone allograft market is flourishing, with ongoing innovations in allograft processing and applications. The use of advanced demineralization techniques has improved the osteoconductive properties of allografts, enhancing their effectiveness in spinal fusion and orthopedic surgeries. Additionally, regulatory agencies like the FDA are facilitating faster approvals for new allograft products, fostering a competitive environment. Collaborations between hospitals and tissue banks have also increased, promoting better access to high-quality allografts. Furthermore, educational initiatives are raising awareness among healthcare professionals about the benefits and applications of bone allografts, contributing to market growth.
• China: China is witnessing rapid advancements in the bone allograft market, driven by an increasing aging population and a rise in orthopedic surgeries. The government has been investing in healthcare infrastructure, leading to better access to bone allograft products. Local companies are partnering with international firms to enhance technology and processing methods. Recent regulatory changes are streamlining the approval process for bone allografts, encouraging innovation and improving safety standards. Additionally, growing awareness among surgeons regarding the benefits of allografts for reconstructive procedures is driving demand, positioning China as a significant player in the global market.
• Germany: The German bone allograft market is characterized by stringent regulatory standards and a strong emphasis on research and development. Recent developments include advances in graft processing techniques, which enhance the viability and effectiveness of allografts. The country is also focusing on biocompatibility and the use of composite materials that combine allografts with synthetic options. Furthermore, German universities and research institutions are actively involved in clinical studies, contributing to a deeper understanding of allograft applications. Increased collaboration between manufacturers and healthcare providers is further promoting the integration of allografts in surgical practices across various specialties.
• India: In India, the bone allograft market is rapidly evolving due to an increasing prevalence of orthopedic conditions and a growing awareness of advanced treatment options. The market has seen the emergence of several tissue banks that comply with international standards for allograft processing. Regulatory bodies are improving oversight and streamlining approval processes, allowing for faster access to quality products. Additionally, there is a growing emphasis on training healthcare professionals about the benefits and techniques associated with bone allografts. As healthcare infrastructure improves, access to these vital products is expected to increase, driving further growth in the market.
• Japan: Japan is making significant strides in the bone allograft market, characterized by innovations in regenerative medicine and surgical techniques. The country is focusing on developing safer, more effective allograft products, supported by advanced research in tissue engineering. Regulatory agencies are facilitating the introduction of new technologies, allowing for quicker integration of innovative allografts into clinical practice. Furthermore, educational initiatives aimed at healthcare professionals are enhancing knowledge about allograft applications in orthopedic and dental surgeries. As the demand for minimally invasive procedures rises, the market is expected to continue growing, driven by these advancements.

Features of the Global Bone Allograft Market

Market Size Estimates: Bone allograft market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Bone allograft market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Bone allograft market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the bone allograft market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bone allograft market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bone allograft market by type (cortical bone allografts, cancellous bone allografts, corticocancellous bone allografts, and demineralized bone matrices), application (dental, spine, reconstruction & traumatology, and others), end use (hospitals & dental clinics, orthopedic & trauma centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bone Allograft Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Bone Allograft Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Bone Allograft Market by Type
  • 3.3.1: Cortical Bone Allografts
  • 3.3.2: Cancellous Bone Allografts
  • 3.3.3: Corticocancellous Bone Allografts
  • 3.3.4: Demineralized Bone Matrices
• 3.4: Global Bone Allograft Market by Application
  • 3.4.1: Dental
  • 3.4.2: Spine
  • 3.4.3: Reconstruction & Traumatology
  • 3.4.4: Others
• 3.5: Global Bone Allograft Market by End Use
  • 3.5.1: Hospitals & Dental Clinics
  • 3.5.2: Orthopedic & Trauma Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Bone Allograft Market by Region
• 4.2: North American Bone Allograft Market
  • 4.2.1: North American Market by Type: Cortical Bone Allografts, Cancellous Bone Allografts, Corticocancellous Bone Allografts, and Demineralized Bone Matrices
  • 4.2.2: North American Market by End Use: Hospitals & Dental Clinics, Orthopedic & Trauma Centers, and Others
• 4.3: European Bone Allograft Market
  • 4.3.1: European Market by Type: Cortical Bone Allografts, Cancellous Bone Allografts, Corticocancellous Bone Allografts, and Demineralized Bone Matrices
  • 4.3.2: European Market by End Use: Hospitals & Dental Clinics, Orthopedic & Trauma Centers, and Others
• 4.4: APAC Bone Allograft Market
  • 4.4.1: APAC Market by Type: Cortical Bone Allografts, Cancellous Bone Allografts, Corticocancellous Bone Allografts, and Demineralized Bone Matrices
  • 4.4.2: APAC Market by End Use: Hospitals & Dental Clinics, Orthopedic & Trauma Centers, and Others
• 4.5: ROW Bone Allograft Market
  • 4.5.1: ROW Market by Type: Cortical Bone Allografts, Cancellous Bone Allografts, Corticocancellous Bone Allografts, and Demineralized Bone Matrices
  • 4.5.2: ROW Market by End Use: Hospitals & Dental Clinics, Orthopedic & Trauma Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bone Allograft Market by Type
  • 6.1.2: Growth Opportunities for the Global Bone Allograft Market by Application
  • 6.1.3: Growth Opportunities for the Global Bone Allograft Market by End Use
  • 6.1.4: Growth Opportunities for the Global Bone Allograft Market by Region
• 6.2: Emerging Trends in the Global Bone Allograft Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bone Allograft Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bone Allograft Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Zimmer Biomet
• 7.2: Medtronic
• 7.3: Lynch Biologics
• 7.4: Biomatlante
• 7.5: Stryker
• 7.6: Royal Biologics
• 7.7: Johnsons & Johnsons
• 7.8: Smith & Nephew
• 7.9: Baxter
• 7.10: Xtant Medical